Gastroenterology

CME Exam 3: Real-time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations that Might be Targeted with Existing Drugs or Used as Biomarkers




CME Exam 3: Real-time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations that Might be Targeted with Existing Drugs or Used as Biomarkers

Source link





Related posts

Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria

Newsemia

Choosing Between Aggressive Treatments for Difficult Bile Duct Stones

Newsemia

Full clip closure of colorectal lesions protects against delayed bleeding

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy